PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF HEPATITIS B OR IMPROVING AGENT OF LIVER FUNCTION COMPRISING PHYLLANTHUS URINARIA EXTRACT CONTAINING ELLAGIC ACID

摘要

PURPOSE: A pharmaceutical composition containing Phyllanthus urinaria extract for preventing and treating hepatitis type B is provided to suppress the secretion of virus e antigen with low cytotoxicity. CONSTITUTION: A pharmaceutical composition for preventing and treating hepatitis type B contains ellagic acid-containing Phyllanthus urinaria extract as an active ingredient. The Phyllanthus urinaria extract is obtained by extracting dried Phyllanthus urinaria with 0.85-0.95% of sodium chloride at pH 6.5-9.5. An agent for improving liver function contains Phyllanthus urinaria extract as an active ingredient. A health functional food composition for preventing and relieving hepatitis type B contains the Phyllanthus urinaria extract as an active ingredient.